English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Senate approves bill with major Medicaid and clean air program cuts

+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

UTHealth Houston offers new hope for Alzheimer's patients through groundbreaking treatment

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

American Lung Association names Michelle McMahon & Allen Wentworth volunteers of year

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

UTHealth Houston provides relief for mother battling rare neurological disorders

+ Pharmaceuticals
Patient Daily | Jun 30, 2025

Baylor expert highlights importance of sunglasses for eye health

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 240
  • 241
  • 242
  • 243
  • 244
  • 245
  • 246
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily